Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide in Chinese RMS patients with ABCG2 mutation evaluation
NCT04410965Phase 4Completed
- Sponsor
- Sanofi
- Start
- May 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started May 2020; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04410965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04410965.